07/18/2025
4:11 PM | Cumbo Alexander (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2025
4:12 PM | Detheux Michel (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2025
4:14 PM | Cumbo Alexander (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2025
4:16 PM | Detheux Michel (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
3:07 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2025
4:29 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2025
3:22 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2025
4:00 PM | 5AM Ventures VI, L.P. (Filed by)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form SCHEDULE 13D/A | |
07/02/2025
3:40 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2025
4:15 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2025
8:18 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for VOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vor Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
05/23/2025
4:45 PM | Namouni Fouad (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Patterson Matthew R (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Beckman Daniella (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Lubner David Charles (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Lundberg Sven Ante (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Kalir Erez (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:45 PM | Resnick Joshua (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:47 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
3:05 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:35 AM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
3:30 PM | Choi Han Wook (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
11:15 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form EFFECT | |
03/28/2025
3:33 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form PRE 14A | |
03/20/2025
3:45 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/20/2025
3:48 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/20/2025
3:01 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2025
3:29 PM | Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:34 AM | FMR LLC (Filed by)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
3:35 PM | Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:36 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:37 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:01 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
8:19 PM | Choi Han Wook (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:20 PM | Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:22 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:23 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
11:15 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form EFFECT | |
01/29/2025
4:24 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 424B3 | |
01/21/2025
3:24 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/08/2025
5:39 PM | Kalir Erez (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Genesis 14:13-17 [HIDDEN MEANING?] (Ad) A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthright” — a $150 trillion wealth vault that’s remained untouched for over a century.
Jim Rickards believes President Trump is about to unleash it — and investors who move first could come out on top. The full story is now available. Watch the presentation on America’s hidden birthright |
01/08/2025
5:41 PM | Kalir Erez (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
8:06 AM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:53 PM | Reprogrammed Interchange LLC (Filed by)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form SCHEDULE 13D | |
01/02/2025
6:37 PM | Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
6:42 PM | Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
5:51 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form SCHEDULE 13D/A | |
12/30/2024
5:52 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:17 PM | Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2024
8:05 AM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
6:39 AM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:33 PM | Paradigm Biocapital Advisors LP (Filed by)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
| Form SC 13G/A | |
11/08/2024
3:15 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:15 PM | Quinlan Amy (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:20 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Quinlan Amy (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
3:16 PM | Choi Han Wook (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2024
3:17 PM | Choi Han Wook (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
6:05 AM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:06 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:01 PM | Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:29 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:30 PM | ANG ROBERT (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
